派林生物

- 000403

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
派林生物(000403) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入137,481.3370,907.1826,086.03240,518.84149,347.23
营业收入137,481.3370,907.1826,086.03240,518.84149,347.23
二、营业总成本103,326.9857,234.9321,830.96175,333.41110,675.00
营业成本68,674.2636,341.5913,457.73115,144.3375,160.73
营业税金及附加1,171.14663.06281.301,679.511,063.11
销售费用20,225.7212,101.344,143.3539,956.8821,751.32
管理费用12,164.808,130.763,886.2616,547.7012,174.50
财务费用-4,285.08-2,939.28-1,365.12-5,531.49-3,887.15
研发费用5,376.142,937.451,427.447,536.484,412.47
资产减值损失----------
公允价值变动收益894.73565.60273.55492.91281.87
投资收益435.72259.3861.67303.78263.34
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润37,263.5616,136.356,317.3566,342.9539,821.31
加:营业外收入328.34107.510.02251.5214.03
减:营业外支出585.00310.9325.68555.25181.80
其中:非流动资产处置损失----------
四、利润总额37,006.9015,932.936,291.6966,039.2139,653.53
减:所得税费用4,425.571,632.83669.867,270.204,599.02
五、净利润32,581.3314,300.105,621.8358,769.0135,054.51
归属于母公司所有者的净利润32,619.5414,313.725,637.6158,713.1534,953.95
少数股东损益-38.21-13.62-15.7855.86100.57
六、每股收益
基本每股收益(元/股)0.44600.19580.07710.80350.4784
稀释每股收益(元/股)0.44600.19580.07710.80320.4780
七、其他综合收益2.102.56-0.913.567.66
八、综合收益总额32,583.4314,302.665,620.9258,772.5835,062.18
归属于母公司所有者的综合收益总额32,621.6414,316.275,636.6958,716.7134,961.61
归属于少数股东的综合收益总额-38.21-13.62-15.7855.86100.57
下载全部历史数据到excel中 返回页顶